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Comparing Adherence 
in Cardiac Clinic Versus 
General Outpatient 
Clinic: Few Concerns and 
Way Forward
Dear Sir,
We read the article titled “antihypertensive medications 
adherence among Nigerian hypertensive subjects in a 
specialist clinic compared to a general outpatient clinic.”[1] 
The study discusses the role of special clinic on adherence 
to medication among hypertensive patients. Adherence 
to medication has impact on treatment outcomes and the 
prevention of complications. As per rule of halves, only 
12.5% of hypertensive patients are treated adequately, there 
are lacunae in diagnosing and treating hypertensive patients 
due to inefficiencies in the health system. Even among those 
12.5% of hypertensive patients, patient-level factors play an 
important role in the adherence to the advice of healthcare 
providers. Hence, there is a need to assess patient’s adherence 
to medication and its associated factors to plan for targeted 
interventions toward individuals with poor adherence. 
There is an advocacy toward setting up special clinics for 
non-communicable diseases, and many developing countries 
have adopted this strategy. Since this study compares 
patient-level outcomes on adherence in special clinic versus 
general outpatient clinic, the study results will be of great 
use to policymakers in deciding on appropriate intervention. 
However, we have to take into account few issues before 
considering the study findings.
Though the authors mention from where the patients were 
recruited, it would have been better if the study setting was 
elaborately described. Information on the availability of 
services and patient load per provider were not mentioned, 
and these differences in special clinic and general outpatient 
clinic may have impact on the adherence level. It would 
have been better if authors had mentioned the total number 
of hypertensive patients treated in both the clinics and the 
proportion willing to participate. Furthermore, comparing 
the characteristics of non-respondents in each clinic would 
have given more credibility to the results by justifying against 
selection bias. Since the authors mention their main aim was to 
find the difference in adherence between these two modalities, 
sample size should have been estimated. Otherwise the study 
should have included all the eligible participants in the study 
setting.
In the results section under Table 1, authors have used t-test to 
compare the determinants across various levels of adherence. 
Since adherence was categorized into three levels, one-way 
ANOVA with appropriate post-hoc tests would have been the 
appropriate statistical method. Using t-test between any two 
groups among the three increases type 1 error, resulting in 
erroneous conclusions. Since the determinants, such as duration 
of hypertension, monthly income, and blood sugar level, are not 
following the normality assumptions for t-test, nonparametric 
tests would be appropriate. To negate confounding effects and 
identify the independent effect of special clinic on adherence, 
multivariate regression including important variables would 
have served the purpose. As Morisky Medication Adherence 
Scale-8 (MMAS-8) is not an interval scale, the mean score cannot 
be compared by t-test as illustrated in Table 3 of the article.[2] It 
is ideal to categorize into a nominal variable as validated under 
MMAS-8 and compare across the clinic type as shown in Table 2.
In general, facility-based studies pose a threat of “social 
desirability bias” in assessing adherence as patients tend to 
hide poor adherence from healthcare provider. As this study 
was conducted in a health facility, the possibility of desirability 
bias cannot be ruled out. MMAS-8 is an established reliable and 
valid tool to measure adherence for antihypertensive medication. 
As self-reported MMAS-8, questionnaire is not validated in 
Nigerian population (language), this may have an effect on 
measuring adherence. Alternate ways to assess the adherence 
in an objective way include chemical analysis, medication 
possession ratio, and pill count.[3] Though chemical analysis 
is the most appropriate one, it may not be feasible in resource 
limited settings. In a study among Spanish hypertensive patients, 
non-adherence was captured better using pill count as compared 
to validated questionnaires which intend to measure adherence.[4] 
Pill refilling status and pharmacy claims are the intermediate 
options left between subjective and more objective methods. 
Details on pill refills could be easily extracted from appropriately 
maintained drug registers. With increase in use of hospital 
information systems globally in the last decade, integrating 
pharmacy registers with individual patient electronic records 
will help in measuring the adherence in an objective manner.
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